News & Updates

Show Multimedia Only

Benralizumab reduces flare events in patients with hypereosinophilic syndrome

19 Dec 2025 by

Treatment with benralizumab is associated with a significantly reduced risk of flares in patients with hypereosinophilic syndrome (HES) compared with placebo, according to the NATRON study presented at ASH 2025.

Benralizumab reduces flare events in patients with hypereosinophilic syndrome

19 Dec 2025

HPV vaccine uptake remains low in SG despite improved awareness

18 Dec 2025 by

Knowledge of human papillomavirus (HPV) vaccination has improved in Singapore following government efforts to enhance cervical cancer awareness through national campaigns and policy changes. However, this has not translated to an increase in vaccine acceptance rates, according to a study.

HPV vaccine uptake remains low in SG despite improved awareness

18 Dec 2025

Lactulose, Tai chi prevent falls in patients with cirrhosis, portal hypertension

18 Dec 2025 by

The LIVE-SMART trial presented at AASLD 2025 shows that lactulose and Tai chi may prevent falls in individuals with cirrhosis and portal hypertension.

Lactulose, Tai chi prevent falls in patients with cirrhosis, portal hypertension

18 Dec 2025

No long-term disability risks with physical activity in people with low back pain

17 Dec 2025

Physical activity appears to pose transient risks of low back pain (LBP) flares but not functional limitations in the long term, according to a prospective, longitudinal case-crossover study.

No long-term disability risks with physical activity in people with low back pain

17 Dec 2025

Atopic dermatitis may inhibit growth in children, but dupilumab helps

17 Dec 2025

Children with atopic dermatitis (AD) are at greater risk of impaired linear growth, but treatment with dupilumab may lessen the risk, suggests a study.

Atopic dermatitis may inhibit growth in children, but dupilumab helps

17 Dec 2025

Ustekinumab biosimilar shows potential against moderate-to-severe psoriasis

17 Dec 2025

Outcomes are similar among patients with moderate-to-severe psoriasis who continued treatment with ustekinumab and those who switched to BAT2206, a drug being developed as a biosimilar of ustekinumab, according to a study.

Ustekinumab biosimilar shows potential against moderate-to-severe psoriasis

17 Dec 2025

Insulin glargine plus lixisenatide improves outcomes in Chinese adults with T2D

17 Dec 2025 by

Treatment with iGlarLixi* resulted in better clinical outcomes than IDegAsp** in Chinese adults with type 2 diabetes (T2D), regardless of age or disease duration at baseline, according to a post hoc analysis of the phase III Soli-D study presented at ATTD-ASIA 2025.

Insulin glargine plus lixisenatide improves outcomes in Chinese adults with T2D

17 Dec 2025

Chemo plus targeted therapy extends survival in advanced BRAF-mutated CRC

16 Dec 2025 by

The combination of chemotherapy and anti-EGFR/BRAF therapy provides optimal survival benefits to patients with advanced BRAF-mutated colorectal cancer (CRC), according to a study.

Chemo plus targeted therapy extends survival in advanced BRAF-mutated CRC

16 Dec 2025

Add-on ON101 cost-effective for DFUs

16 Dec 2025 by

An economic analysis shows the cost-effectiveness of adding ON101 to general wound care (GWC) for the treatment of diabetic foot ulcers (DFUs) in individuals with type 2 diabetes (T2D) in Singapore, with robust results across subgroup and sensitivity analyses.

Add-on ON101 cost-effective for DFUs

16 Dec 2025

Tinengotinib shows promising activity against cholangiocarcinoma

16 Dec 2025

In patients with cholangiocarcinoma with FGFR2 fusions that progressed following FGFR inhibitor therapy, tinengotinib has demonstrated potential antitumour activity in a phase II study.

Tinengotinib shows promising activity against cholangiocarcinoma

16 Dec 2025

News & Updates

Showing Pharmacy articles

Showing

Specialty:

Benralizumab reduces flare events in patients with hypereosinophilic syndrome

Benralizumab reduces flare events in patients with hypereosinophilic syndrome

HPV vaccine uptake remains low in SG despite improved awareness

HPV vaccine uptake remains low in SG despite improved awareness

Lactulose, Tai chi prevent falls in patients with cirrhosis, portal hypertension

Lactulose, Tai chi prevent falls in patients with cirrhosis, portal hypertension

No long-term disability risks with physical activity in people with low back pain

No long-term disability risks with physical activity in people with low back pain

Atopic dermatitis may inhibit growth in children, but dupilumab helps

Atopic dermatitis may inhibit growth in children, but dupilumab helps

Ustekinumab biosimilar shows potential against moderate-to-severe psoriasis

Ustekinumab biosimilar shows potential against moderate-to-severe psoriasis

Insulin glargine plus lixisenatide improves outcomes in Chinese adults with T2D

Insulin glargine plus lixisenatide improves outcomes in Chinese adults with T2D

Chemo plus targeted therapy extends survival in advanced BRAF-mutated CRC

Chemo plus targeted therapy extends survival in advanced BRAF-mutated CRC

Add-on ON101 cost-effective for DFUs

Add-on ON101 cost-effective for DFUs

Tinengotinib shows promising activity against cholangiocarcinoma

Tinengotinib shows promising activity against cholangiocarcinoma